Skip to main content
Clinical Trials/NCT06125236
NCT06125236RecruitingNot Applicable

Registration of Acute Ischemic Stroke With Large and Medium-sized Vascular Occlusion in Southwest China(LMVOS)

Zhengzhou Yuan1 site in 1 country8,000 target enrollmentStarted: November 9, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
8,000
Locations
1
Primary Endpoint
modified Rankin Scale (mRS) score

Study Overview

Brief Summary

This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.

Detailed Description

LMVOS is a prospective, real-world registry lasting for 22 years. A total of 8000 patients with large- or medium-vessel occlusion will be enrolled.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The clinical diagnosis is acute ischemic stroke with large- or medium- vessel occlusion (the criteria followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018).
  • Informed consent from the patient or surrogate.

Exclusion Criteria

  • No additional exclusion criteria.

Outcomes

Primary Outcomes

modified Rankin Scale (mRS) score

Time Frame: 90±7 days

Ordinal distribution of mRS at 90±7 days; modified Rankin scale (range, 0 to 6, with a score of 0 indicating no disability, 1 no clinically significant disability, 2 slight disability, 3 moderate disability but remaining able to walk unassisted, 4 moderately severe disability, 5 severe disability, and 6 death)

Secondary Outcomes

  • Excellent functional outcome(90±7 days)
  • Good functional outcome(90±7 days)
  • mRS 0-3(90±7 days)
  • Change of National Institutes of Health Stroke Scale (NIHSS)(7 days)
  • Symptom-to-thrombolysis time (STT)(24 hours)
  • Door-to-Needle Time(24 hours)
  • Door-to-Puncture Time (DPT)(24 hours)
  • Onset-to-recanalization time(24 hours)
  • Door-to-Recanalization Time (DRT)(24 hours)
  • Puncture-to-recanalization time(24 hours)

Investigators

Sponsor
Zhengzhou Yuan
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Zhengzhou Yuan

Deputy Director of Stroke Center

The Affiliated Hospital Of Southwest Medical University

Study Sites (1)

Loading locations...

Similar Trials